Intravenous (IV) Hydration Therapy Market Report 2026

Intravenous (IV) Hydration Therapy Market Overview

• Intravenous (IV) Hydration Therapy market size has reached to $3.04 billion in 2025 • Expected to grow to $4.85 billion in 2030 at a compound annual growth rate (CAGR) of 9.9% • Growth Driver: Rising Prevalence Of Chronic Diseases Fuels Growth In The Intravenous (IV) Hydration Therapy Market • Market Trend: Sterile Solution To Address The Growing Demand For CBD Infusion • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Intravenous (IV) Hydration Therapy Market?

Intravenous (IV) hydration therapy is a straightforward procedure that involves inserting a tiny IV into the arm to administer fluids straight into the bloodstream. It helps with treatment by allowing the body to receive nutrients, blood, water, and medications more quickly through the circulatory system. The main service types of intravenous (IV) hydration therapy are immune boosters, energy boosters, skin care, migraine, and others. Immunity boosters refer to products that assert that they can strengthen the immune system and reduce your risk of contracting illnesses. The various components include medicated, and non-medicated, which are used by various end-users such as hospitals and clinics, wellness centers and spas, home healthcare, and others.

What Is The Intravenous (IV) Hydration Therapy Market Growth Forecast?

The intravenous (iv) hydration therapy market size is expected to see strong growth in the next few years. It will grow to $4.85 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to growth of wellness and preventive healthcare services, increasing popularity of home healthcare solutions, rising demand for quick recovery and energy boosting therapies, expansion of concierge and mobile iv therapy services, growing consumer focus on hydration and nutrient optimization. Major trends in the forecast period include rapid expansion of wellness and lifestyle iv therapy services, increasing consumer preference for preventive and recovery care, growing adoption of mobile and at-home iv hydration services, rising demand for customized iv infusion formulations, expansion of iv therapy beyond clinical settings.

Global Intravenous (IV) Hydration Therapy Market Segmentation

1) By Service: Immune Boosters, Energy Boosters, Skin Care, Migraine, Other Services 2) By Component: Medicated, Non-Medicated 3) By End-User: Hospitals And Clinics, Wellness Centers And Spas, Home Healthcare, Other End-Users Subsegments: 1) By Immune Boosters: Vitamin C Infusion, Zinc Infusion, Glutathione Infusion 2) By Energy Boosters: B-Complex Vitamins Infusion, Amino Acids Infusion, Electrolyte Solutions 3) By Skin Care: Hydration Infusion, Anti-Aging Infusion, Detox Infusion 4) By Migraine: Pain Relief Infusion, Magnesium Infusion, Hydration Infusion 5) By Other Services: Hangover Relief Infusion, Weight Loss Infusion, Athletic Performance Infusion

What Is The Driver Of The Intravenous (IV) Hydration Therapy Market?

The rise in the prevalence of chronic diseases is expected to propel the growth of the intravenous (IV) hydration therapy market going forward. Chronic diseases are long-lasting health conditions, typically persisting for three months or more, requiring ongoing management. The growing prevalence of chronic diseases is partly due to aging populations because as people live longer, they are more likely to develop diabetes, heart disease, and arthritis. Intravenous (IV) hydration therapy supports the management of chronic diseases by quickly restoring fluid and electrolyte balance, improving nutrient delivery, reducing fatigue, and enhancing overall cellular function, thereby helping patients better tolerate treatments and maintain daily health. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal public health agency, 76.4% of US adults representing about 194 million people reported having one or more chronic conditions in 2023, with prevalence at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the rise in the prevalence of chronic diseases is driving the growth of the intravenous (IV) hydration therapy industry.

Key Players In The Global Intravenous (IV) Hydration Therapy Market

Major companies operating in the intravenous (iv) hydration therapy market are Revitalist, JW Life Science Corporation, Pfizer Inc., Fresenius Kabi AG, Medtronic Plc., Drip Hydration, Amanta Healthcare Ltd., Becton Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Sippex IV bag, REVIV, Braun Melsungen AG, The IV Doc Inc., Terumo Medical Corporation, Grifols S.A., Core IV Therapy LLC, Hospira, Teleflex Incorporated, Sichuan Kelun Pharmaceutical Co.Ltd., ICU Medical Inc., Vygon SAS.

Global Intravenous (IV) Hydration Therapy Market Trends and Insights

Major companies in the intravenous (IV) hydration therapy market are focused on developing sterile solutions, such as CBD isolate, to address the growing demand for CBD infusion and to gain a competitive edge in the market. CBD isolate is the purest form of cannabidiol, containing no other cannabinoids or plant compounds. For instance, in September 2023, Apex Labs CBD, a US-based company that provides a diverse choice of high-quality CBD products, launched Pico IV, a CBD isolate designed for intravenous (IV) therapy. Pico IV's sterile solution allows for safe intravenous use, addressing the demand for CBD infusion in the rapidly growing IV hydration therapy market. With a size reduction of the CBD molecule to a picometer, Pico IV offers maximum absorption and is exclusively available to licensed IV therapy providers for online purchase.

What Are Latest Mergers And Acquisitions In The Intravenous (IV) Hydration Therapy Market?

In September 2025, Next Health Management Group LLC (Next Health), a US-based provider of health-optimization, longevity, and wellness clinic services, acquired Lindora Franchise, LLC for an undisclosed amount. With this acquisition, Next Health gains access to Lindora’s established network of medically supervised wellness clinics offering IV hydration therapy, metabolic-health solutions, hormone replacement therapies, and weight-management programs, thereby enhancing its IV hydration therapy capabilities while improving its service breadth, clinic footprint, and operational scale across the wellness market. Lindora is a US-based provider of metabolic-health and wellness clinics, known for its integrated approach combining IV hydration therapy, vitamin infusions, weight-loss treatments, and clinically guided wellness programs.

Regional Outlook

North America was the largest region in the intravenous (IV) hydration therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Intravenous (IV) Hydration Therapy Market?

The intravenous (IV) hydration therapy market includes revenues earned by entities by providing normal saline, half-normal saline, lactated ringers, dextrose, and related detoxification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Intravenous (IV) Hydration Therapy Market Report 2026?

The intravenous (iv) hydration therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous (iv) hydration therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.